- Oops!Something went wrong.Please try again later.
Phoenix, Arizona--(Newsfile Corp. - December 22, 2020) - The Stock Day Podcast welcomed American Cannabis Company, Inc. (OTCQB: AMMJ) ("the Company"), a company offering end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. CEO of the Company, Terry Buffalo, joined Stock Day host Everett Jolly.
Jolly began the interview by commenting on a recent press release by the Company detailing the execution of a non-binding letter of intent to purchase assets of Naturaleaf. "We've been looking for over a year to make an acquisition here in Colorado," explained Buffalo. "Luckily, we came across Naturaleaf in Colorado Springs," he continued. Buffalo then shared that the acquisition assets include three retail dispensaries, as well as a cultivation operation. "Naturaleaf is very compliant. Their financials are in order, and I can't say enough about their team."
"We have started doing our due diligence and the audit process is underway. We hope to have this closed by the first quarter of 2021," shared Buffalo, adding that Naturaleaf is already established as a profitable company.
"What kind of impact will this have if it goes through?" asked Jolly. "It definitely will more than double our gross revenue from the previous year," said Buffalo.
Jolly then asked about the potential of additional acquisitions in the near future. "We're continuing to look in the Colorado market. We do have a couple of deals that we're still negotiating," explained Buffalo. "Our primary focus right now is in the Colorado market; we do see opportunity here."
The conversation then turned to the discussion of new services launching in 2021. Buffalo elaborated on the Company's cultivation management services and accounting services, which have received great feedback so far. "One of the things we're really proud about is the new design of our Cultivation Cube™," shared Buffalo. "One additional thing we've been able to do is offer [Cultivation Cube™] financing for qualified investors, not [directly] through American Cannabis Company, but through a third party."
To close the interview, Buffalo thanked his shareholders for their continued patience and support. "We've always been very slow and methodical in our approach. We're looking for opportunities that are going to create value for our shareholders," said Buffalo, noting the potential of the acquisition of Naturaleaf. "We're definitely looking for opportunities to bring to the company that will increase our shareholder value and provide us with positive cash flow."
To hear Terry Buffalo's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7756353-american-cannabis-company-inc-discusses-non-binding-loi-for-the-acquisition-of-naturaleaf-with
About American Cannabis Company, Inc.
American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis and hemp industries. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We are continuing to grow the Company by promoting our operational management services, and license the American Cannabis Company brand, as well as continuing to analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® - Winner of the High Times S.T.A.S.H Award for "Best Potting Mix", The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry specific custom product solutions.
For more information about American Cannabis Company, please visit:
For more information on Naturaleaf, please visit:
https://www.youtube.com/watch?v=aENC4aeNZis (High Density Cultivation System)
https://www.youtube.com/watch?v=e9rNxFph_tQ&t (Cultivation Cube)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum Living Soils®)
Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
Cannabis Remains an Illegal Schedule 1 Drug Under Federal Law
Cannabis and its derivatives are considered illegal "Schedule 1" drugs under the Controlled Substances Act (21 U.S.C. § 811). As such, Cannabis and its derivatives are viewed as being highly addictive and having no medical value. The United States Drug Enforcement Agency enforces the Controlled Substances Act, and persons violating it are subject to federal criminal prosecution. The criminal penalty structure in the Controlled Substances Act is determined based on the specific predicate violations, including but not limited to: simple possession, drug trafficking, attempt and conspiracy, distribution to minors, trafficking in drug paraphernalia, money laundering, racketeering, environmental damage from illegal manufacturing, continuing criminal enterprise, and smuggling. A first conviction under the Controlled Substances Act can generally result in possible fines from $250,000 to $50 million dollars, and incarceration for periods generally from five and up to forty years. For a second conviction, fines increase generally from $500,000 to $75 million dollars, and incarceration for periods generally from ten years to twenty years to life.
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.
Stock Day Media
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/70812